CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujii, Y.
Right arrow Articles by Toyooka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujii, Y.
Right arrow Articles by Toyooka, H.

Canadian Journal of Anesthesia, Vol 41, 291-294, Copyright © 1994 by Canadian Anesthesiologists' Society

ARTICLES

Reduction of postoperative nausea and vomiting with granisetron

Y Fujii, H Tanaka and H Toyooka
Department of Anaesthesiology, Toride Kyodo General Hospital, Ibaraki, Japan.

The antiemetic effects of granisetron, a selective 5-hydroxy-tryptamine type 3 receptor antagonist, on postoperative nausea and vomiting were studied and compared with placebo and metoclopramide in 60 patients undergoing general anaesthesia for major gynaecological surgery. The patients received a single i.v. dose of either granisetron (3 mg, n = 20) metoclopramide (10 mg, n = 20), or placebo (saline, n = 20) immediately after recovery from anaesthesia. The effects were assessed during the first three and the next 21 hr after recovery from anaesthesia by means of a nausea and vomiting score; 0 = no emetic symptoms, 1 = nausea, 2 = vomiting. The mean scores during 0-3 hr were 0.8, 0.1 and 0.1 after administration of placebo, metoclopramide and granisetron, respectively; the corresponding scores during 3-24 hr were 0.6, 0.5 and 0.1. The scores of the metoclopramide and the granisetron groups were different from the placebo group in the first three hours (P < 0.05). Although there were no differences in the scores during 0-3 hr between the metoclopramide and the granisetron groups, there were differences during 3-24 hr (P < 0.05). It is concluded that granisetron is superior to metoclopramide in the long-term prevention of postoperative nausea and vomiting after anaesthesia.


This article has been cited by other articles:


Home page
 Canadian J. AnesthesiaHome page
P. S. Loewen, C. A. Marra, and P. J. Zed
5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting
Can J Anesth, October 1, 2000; 47(10): 1008 - 1018.
[Abstract] [PDF]

Home page
 Anesth. Analg.Home page
P. Kranke, C. C. Apfel, N. Roewer, and Y. Fujii
Reported Data on Granisetron and Postoperative Nausea and Vomiting by Fujii et al. Are Incredibly Nice! • Response
Anesth. Analg., April 1, 2000; 90(4): 1004 - 1007.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y. Fujii, Y. Saitoh, H. Tanaka, and H. Toyooka
Ramosetron for Preventing Postoperative Nausea and Vomiting in Women Undergoing Gynecological Surgery
Anesth. Analg., February 1, 2000; 90(2): 472 - 472.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y. Fujii, Y. Saitoh, H. Tanaka, and H. Toyooka
Comparison of Ramosetron and Granisetron for Preventing Postoperative Nausea and Vomiting After Gynecologic Surgery
Anesth. Analg., August 1, 1999; 89(2): 476 - 476.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Canadian Anesthesiologists' Society.